Skip to main content

13-07-2018 | Rheumatoid arthritis | Article

The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: A mixed methods study

Verhoef LM et al. Rheumatology (Oxford) 2018: key205. doi: 10.1093/rheumatology/key205

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics

EULAR 2020 E-Congress hub

Access the latest news and expert video commentary from the EULAR 2020 E-Congress.

Image Credits